Investigation of the structural requirement for inhibiting HIV integrase: QSAR study

D. Finzi, J. Blankson, J. D. Siliciano, J. B. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. C. Quinn, R. E. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant and R. F. Siliciano, Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, Nat. Med. 5 (1999) 512-517; DOI: 10.1038/8394.10.1038/8394Search in Google Scholar

S. G. Deeks, M. Smith, M. Holodniy and J. O. Kahn, HIV-1 protease inhibitors. A review for clinicians, JAMA 277 (1997) 145-153; DOI: 10.1001/jama.277.2.145.10.1001/jama.277.2.145Search in Google Scholar

J. Martinez-Picado, M. P. DePasquale, N. Kartsonis, G. J. Hanna, J. Wong, D. Finzi, E. Rosenberg, H. F. Günthard, L. Sutton, A. Savara, C.J. Petropoulos, N. Hellmann, B. D. Walker, D. Richman, R. Siliciano and R. T. D'Aquila, Antiretroviral resistance during successful therapy of HIV type 1 infection, Proc. Natl. Acad. Sci. USA 97 (2000) 10948-10953.10.1073/pnas.97.20.10948Search in Google Scholar

C. L. Kuiken, B. Foley, B. Hahn, P. A. Marx, F. McCutchan, J. Mellors, J. Mullins, S. Wolinsky and B. Korber, HIV Sequence Compendium 2000, Theoretical Biology and Biophysics Group, Los Alamos National Labatory: Los Alamos, Wiley, New York 2000.Search in Google Scholar

P. O. Brown, Integration, in Retroviruses (Eds. J. M. Coffin, S. H. Hughes and H. E. Varmus), Cold Spring Harbor Laboratry Press, Cold Spring Harbor, New York 1997, pp. 161-203.Search in Google Scholar

E. Asante-Appiah and A. M. Skalka, HIV-1 integrase: structural organization, conformational changes, and catalysis, Adv. Virus Res. 52 (1999) 351-369; DOI: 10.1016/S0065-3527(08)60306-1.10.1016/S0065-3527(08)60306-1Search in Google Scholar

N. J. Anthony, HIV-1 integrase: a target for new AIDS chemotherapeutics, Curr. Top. Med. Chem. 4 (2004) 979-990; DOI: 10.2174/1568026043388448.10.2174/156802604338844815134552Search in Google Scholar

T. K Chiu and D. R. Davies, Structure and function of HIV-1 integrase, Curr. Top. Med. Chem. 4 (2004) 965-977; DOI: 10.2174/1568026043388547.10.2174/156802604338854715134551Search in Google Scholar

A. Kovatcheva, G. Buchbauer, A. Golbraikh and P. Wolschann, QSAR modeling of alpha-campholenic derivatives with sandalwood odor, J. Chem. Inf. Comput. Sci. 43 (2003) 259-266; DOI: 10.1021/ci020296n.10.1021/ci020296n12546561Search in Google Scholar

N. Dessalew and P. V. Bharatam, 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: An insight into the criteria for selectivity, Eur. J. Med. Chem. 42 (2007) 1014-1027; DOI: 10.1016/j.ejmech.2007.01.010.10.1016/j.ejmech.2007.01.01017335939Search in Google Scholar

N. Dessalew, D. S. Patel and P. V Bharatam, 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3b inhibitors, J. Mol. Graph. Mod. 25 (2007) 885-895; DOI: 10.1016/j.jmgm.2006.08.009.10.1016/j.jmgm.2006.08.00917018257Search in Google Scholar

N. Dessalew, P. V. Bharatam and S. K. Singh, 3D-QSAR CoMFA study on aminothiazole derivatives as cyclin-dependent kinase 2 inhibitors, QSAR Comb. Sci. 26 (2007) 85-91; DOI: 10.1002/qsar.200630032.10.1002/qsar.200630032Search in Google Scholar

N. Dessalew, QSAR study on aminophenylbenzamides and acrylamides as histone deacetylase inhibitors: An insight into the structural basis of antiproliferative activity, Med. Chem. Res. 7 (2008), 449-460; DOI: 10.1007/s00044-007-9085-9.10.1007/s00044-007-9085-9Search in Google Scholar

D. C. Meadows, T. B. Mathews, T. W. North, M. J. Hadd, C. L. Kuo, N. Neamati and J. Gervay-Hague, Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors, J. Med. Chem. 48 (2005) 4526-4534; DOI: 10.1021/jm049171v.10.1021/jm049171v15999991Search in Google Scholar

J. A. Grobler, K. Stillmock, B. Hu, M. Witmer, P. Felock, A. S. Espeseth, A. Wolfe, M. Egbertson, M. Bourgeois, J. Melamed, J. S. Wai, S. Young, J. Vacca and D. J. Hazuda, Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes, Proc. Natl. Acad. Sci. USA 99 (2002) 6661-6666; DOI: 10.1073/pnas.092056199.10.1073/pnas.09205619912445911997448Search in Google Scholar

W. G. Verschueren, I. Dierynck, I. E. Katie, L. Hu, M. J. Paul, G. Boonants, M. E. Pille, F. D. Frits, K. Hertogs, L. N. Dominique, G. Surleraux, B. T. Piet and P. Wigerinck, Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 Integrase, J. Med. Chem. 48 (2005) 1930-1940; DOI: 10.1021/jm049559q.10.1021/jm049559q15771437Search in Google Scholar

A. Verloop, W. Hoogenstraaten and J. Tipker, Development and Application of new Steric Substituent Parameters, in Drug Design (Ed. E. J. Ariens), Academic Press, New York 1976, pp. 165-207.10.1016/B978-0-12-060307-7.50010-9Search in Google Scholar

A. Verloop and J. Tipker, Use of linear free energy related and other parameters in the study of fungicidal selectivity, Pest. Sci. 7 (1976) 379-390.10.1002/ps.2780070410Search in Google Scholar

Verloop and J. Tipker, A comparative study of new parameters in drug design, in Biological Activity and Chemical Structure (Ed. J. A. Keverling Buisman), Elsevier, Amsterdam 1977, pp. 63-81.Search in Google Scholar